HNSBF - Hansa Biopharma AB GAAP EPS of -SEK 3.82 revenue of SEK 26.4M July, 19 2022 02:31 AM Hansa Biopharma AB Hansa Biopharma AB press release ( OTCPK:HNSBF ): Q2 GAAP EPS of -SEK 3.82. Revenue of SEK 26.4M (+486.7% Y/Y). For further details see: Hansa Biopharma AB GAAP EPS of -SEK 3.82, revenue of SEK 26.4M